Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms

被引:86
作者
Marin-Kuan, Maricel [1 ]
Cavin, Christophe [1 ]
Delatour, Thierry [1 ]
Schilter, Benoit [1 ]
机构
[1] Nestle Res Ctr, CH-1000 Lausanne 26, Switzerland
关键词
ochratoxin A; risk assessment; mechanism of action; cell signalling; epigenetic; carcinogenicity; nephrotoxicity;
D O I
10.1016/j.toxicon.2008.04.166
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ochratoxin A (OTA) is a mycotoxin occurring in a wide range of food products. Because of the limitation of human epidemiological data, the safety significance of OTA in food has to rely on animal data, with renal toxicity and carcinogenicity being considered the pivotal effects. The elucidation of the mechanism of action would improve the use of experimental animal data for risk assessment. Direct genotoxicity versus epigenetic mechanisms appears to be a key question. In the present review, the increasingly documented epigenetic cellular effects of OTA and their potential toxicological relevance are discussed. The information available suggests that OTA is unlikely to act through a single, well-defined mechanism of action. Instead, it is proposed that a network of interacting epigenetic mechanisms, including protein synthesis inhibition, oxidative stress and the activation of specific cell signalling pathways, is responsible for OTA carcinogenicity. From a risk assessment perspective, it has to be noted that the mechanisms proposed above depend mainly upon gene expression and enzyme activation, and are, therefore, likely to be thresholded. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 82 条
[1]   Immunotoxic activity of ochratoxin A [J].
Al-Anati, L ;
Petzinger, E .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2006, 29 (02) :79-90
[2]   Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity [J].
Arbillaga, Leire ;
Azqueta, Amaia ;
Ezpeleta, Olga ;
de Cerain, Adela Lopez .
MUTAGENESIS, 2007, 22 (01) :35-42
[3]   EFFECT OF SUPEROXIDE-DISMUTASE AND CATALASE ON THE NEPHROTOXICITY INDUCED BY SUBCHRONICAL ADMINISTRATION OF OCHRATOXIN-A IN RATS [J].
BAUDRIMONT, I ;
BETBEDER, AM ;
GHARBI, A ;
PFOHLLESZKOWICZ, A ;
DIRHEIMER, G ;
CREPPY, EE .
TOXICOLOGY, 1994, 89 (02) :101-111
[4]   Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells [J].
Benesic, A ;
Mildenberger, S ;
Gekle, M .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2000, 439 (03) :278-287
[5]  
Cavin C, 2007, TOXICOL SCI, V96, P30, DOI [10.1093/toxscikfl169, 10.1093/toxsci/kfl169]
[6]   The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation [J].
Cheung, CW ;
Vesey, DA ;
Nicol, DL ;
Johnson, DW .
KIDNEY INTERNATIONAL, 2004, 65 (04) :1272-1279
[7]   ALTERATIONS IN ATP-DEPENDENT CALCIUM-UPTAKE BY RAT RENAL-CORTEX MICROSOMES FOLLOWING OCHRATOXIN A ADMINISTRATION INVIVO OR ADDITION INVITRO [J].
CHONG, X ;
RAHIMTULA, AD .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (07) :1401-1409
[8]   Ochratoxin A: Its cancer risk and potential for exposure [J].
Clark, HA ;
Snedeker, SM .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2006, 9 (2-3) :265-296
[9]   Structural insights into the interaction and activation of histone deacetylase 3 by nuclear receptor corepressors [J].
Codina, A ;
Love, JD ;
Li, Y ;
Lazar, MA ;
Neuhaus, D ;
Schwabe, JWR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) :6009-6014
[10]  
Creppy EE, 1996, FOOD ADDIT CONTAM, V13, P51